Alvorligheden af bivirkningerne ved Docetaxel Winthrop kan forøges, når Docetaxel Winthrop gives i kombination med andre kemoterapeutiske lægemidler.
The severity of adverse events of Docetaxel Winthrop may be increased when Docetaxel Winthrop is given in combination with other chemotherapeutic agents.